Novozymes A/S (OTCMKTS:NVZMY – Get Free Report) was the recipient of a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 1,700 shares, an increase of 1,600.0% from the February 28th total of 100 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average daily volume of 27,500 shares, the days-to-cover ratio is currently 0.1 days.
Novozymes A/S Trading Down 1.3 %
Shares of NVZMY stock traded down $0.76 during trading hours on Thursday, hitting $57.07. The company’s stock had a trading volume of 27,357 shares, compared to its average volume of 19,519. The business has a fifty day moving average of $57.85 and a 200-day moving average of $60.60. Novozymes A/S has a twelve month low of $52.96 and a twelve month high of $72.50. The stock has a market cap of $26.73 billion, a price-to-earnings ratio of 36.12, a P/E/G ratio of 3.87 and a beta of 0.91.
Novozymes A/S Increases Dividend
The business also recently declared a dividend, which will be paid on Wednesday, April 23rd. Shareholders of record on Monday, April 7th will be given a dividend of $0.3758 per share. This is an increase from Novozymes A/S’s previous dividend of $0.17. The ex-dividend date of this dividend is Monday, April 7th. Novozymes A/S’s dividend payout ratio (DPR) is presently 94.94%.
About Novozymes A/S
Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.
Further Reading
- Five stocks we like better than Novozymes A/S
- What is a support level?
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to SellĀ
- How to Invest in Biotech Stocks
- Top 3 Beverage Stocks Pouring Out Profits
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.